American Journal of Infection Control

Health care associated infections (HAI) are responsible for increased length of stay, cost of hospitalization, and high morbidity and mortality. Some authors report that 10-70% of infections can be avoided if prevention and control measures (bundles)

COVID-19 pneumonia is associated with a mortality up to 20% varying by country1 with the number of global deaths over 5 million.2 Antibiotics have been extensively used in COVID-19 patients in intensive care units (ICUs) without a clear indication.3

It is widely acknowledged that effective hand hygiene (HH) among healthcare workers (HCWs) is one of the most important infection prevention strategies available1, 2; and therefore, is a key element of infection prevention and control guidelines.3

Case studies are utilized for training on National Healthcare Safety Network (NHSN) healthcare associated infection surveillance definitions. Item discrimination and item analysis were applied to case studies to identify questions that most

In March 2020, the World Health Organization (WHO) declared the novel coronavirus pandemic (COVID-19) that had spread rapidly around the world and caused thousands of deaths.1 As of 18 September 2021, more than 227 million cases and 4.67 million

Nurses play an important role in the vaccine readiness process and high vaccination rates among nurses are essential to ensuring successful vaccination programs. This study sought to examine whether the intention to get vaccinated varied by race

Clostridioides difficile (C. difficile) is a leading cause of nosocomial infections. It is a spore-forming anaerobic bacillus that is mainly transmitted through direct or indirect contact with infected patients and asymptomatic carriers.1,2 Patients

Due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization (WHO) recommended on March 16, 2020 to carry out nasopharyngeal swabs for the detection of SARS-CoV-2 as extensively as possible to contain the pandemic1:

Focused Multivector Ultraviolet (FMUV) technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 106 plaque forming units (PFUs) of USA-WA1 Washington index patient strain of SARS-CoV-2 and

Surgical site infections (SSIs) are a major cause of postoperative morbidity and mortality, and increase healthcare-related costs.1,2 A multicentre survey carried out among 25 healthcare facilities in the US showed that pneumonia, gastrointestinal